Product Comparison

  Mallinckrodt 00019086250 Bayer Healthcare Pharmaceuticals Inc 50419032512 Genus Medical Technologies 256-1024 GE Healthcare 00407141489

No Image

McKesson # 1015568 768511 971005 709195 695627
Description Cysto-Conray™ II Iothalamate Meglumine 17.2% Injection 250 mL Gadavist™ Gadobutrol 1 mmol / mL Injection 10 mL Vanilla Silq® Barium Sulfate 21 mg / mL, 2.1% Suspension 450 mL Omnipaque® 350 Iohexol 350 mg / mL Injection 50 mL Eovist® Gadoxetate Disodium 181.43 mg / mL Injection 10 mL
Manufacturer # 0001908625050419032512256-10240040714148950419032005
Brand Cysto-Conray™ IIGadavist™Vanilla Silq®Omnipaque® 350Eovist®
Manufacturer MallinckrodtBayer Healthcare Pharmaceuticals IncGenus Medical TechnologiesGE HealthcareBayer Healthcare Pharmaceuticals Inc
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order


Alternate Manufacturer Number 35432202186872
Container Type BottleSingle-Dose VialBottleInfusion BottleVial
Country of Origin UnknownGermanyUnited StatesUnknownGermany
Dosage Form InjectionInjectionSuspensionInjectionInjection
Flavor Vanilla Flavor
Generic Drug Code 35281297842552313287
Generic Drug Name Iothalamate MeglumineGadobutrolBarium SulfateIohexolGadoxetate Disodium
NDC Number 0001908625050419032512693070102420040714148950419032005
Strength 17.2%1 mmol / mL21 mg / mL, 2.1%350 mg / mL181.43 mg / mL
Type IntravenousOral or Rectal
UNSPSC Code 5144150051442202514415775144242151441500
User Pediatric / Adult
Volume 250 mL10 mL450 mL50 mL10 mL
Application Contrast MediaContrast MediaContrast MediaContrast MediaContrast Media
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits
  • Cysto-Conray™ II contrast agent is injectable, ionic, and high osmolar and intended for instillation into the urinary system
  • Each mL of Cysto-Conray™ II contrast agent contains 172 mg of iothalamate meglumine, 0.110 mg of edetate calcium disodium as a stabilizer and 0.115 mg of monobasic sodium phosphate as a buffer
  • The solution provides 8.1% (81 mg/mL) organically bound iodine
  • Cysto-Conray™ II (iothalamate meglumine injection USP 17.2%) is indicated for use in retrograde cystography and cystourethrography
  • Not for intravascular or intrathecal use
  • Safety and effectiveness of Cysto-Conray II for infusion urography have not been established in children under 12 years of age
  • Cysto-Conray II may be introduced by gravity flow using an appropriate venoclysis set or by syringe
  • GADAVIST™ is a gadolinium-based contrast agent indicated for intravenous use in diagnostic magnetic resonance imaging (MRI) in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system
  • Gadavist is formulated at a higher concentration (1 mmol/mL) compared to certain other gadolinium-based contrast agents, resulting in a lower volume of administration
  • Gadavist injection contains 1 mmol gadobutrol/mL (equivalent to 604.72 mg gadobutrol/mL)
  • Case pack of 20 vials (2 inner packs x 10 vials)
  • Store at 25°C (77°F); excursions permitted to 15 - 30°C (59 - 86°F)
  • For oral or rectal administration
  • Each 100 mL contains 2.1 g barium sulfate
  • Includes 6 Flavor Select Foil Packs (2 banana, 2 berry, 2 orange)
  • Protect vials and glass or polymer bottles of OMNIPAQUE from strong daylight and direct exposure to sunlight
  • Store at controlled room temperature of 20 to 25 degrees C (68 to 77 degrees F)
  • OMNIPAQUE Injection in all presentations may be stored in a contrast media warmer for up to one month at 37 degrees C (98.6 degrees F)